National Health Investors NHI Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $375.63M+12.1% | $335.18M+4.8% | $319.84M+15.0% | $278.19M-6.9% | ||
| $26.87M+29.5% | $20.74M+7.4% | $19.31M-15.2% | $22.77M+23.5% | ||
| $80.94M+13.3% | $71.44M+2.1% | $69.97M-1.3% | $70.88M-12.3% | ||
| $238.96M+12.8% | $211.89M+5.5% | $200.88M-16.9% | $241.86M+11.9% | ||
| $238.96M+12.8% | $211.89M+5.5% | $200.88M-16.9% | $241.86M+11.9% | ||
| $57.37M-4.2% | $59.9M+3.0% | $58.16M+29.5% | $44.92M-11.6% | ||
| $23.97M+1.1% | $23.71M+8.8% | $21.8M-11.7% | $24.7M-10.7% | ||
| $3.66M+811% | $402K-27.6% | $555K-2.6% | $570K— | ||
| $142.18M+3.0% | $137.99M+1.7% | $135.66M+104% | $66.4M-40.6% | ||
| 37.9%-3.3pp | 41.2%-1.2pp | 42.4%+18.5pp | 23.9%-13.6pp | ||
| $3.02-3.5% | $3.130.0% | $3.13+111% | $1.48-39.1% | ||
| $3.03-3.5% | $3.14+0.3% | $3.13+111% | $1.48-39.3% | ||
| 187.4M+7.0% | 175.1M+0.9% | 173.6M-4.0% | 180.8M-1.1% | ||
| 186.7M+7.2% | 174.1M+0.3% | 173.6M-3.9% | 180.7M-1.1% | ||
| $10.98M-1.6% | $11.17M-3.0% | $11.51M+17.6% | $9.79M-15.9% | ||
| $1.08M+2,819% | $37K-91.8% | $449K-46.8% | $844K+7.1% | ||
| $0-100% | $6.26M— | $0— | $0— | ||
| $456K-93.2% | $6.68M-54.6% | $14.72M-48.1% | $28.34M-12.8% | ||
| $23.97M+1.1% | $23.71M+8.8% | $21.8M-11.7% | $24.7M-10.7% | ||
| $271.6M+5.7% | $257.05M+3.1% | $249.23M+14.5% | $217.7M-19.7% | ||
| $1.57M— | $0— | $0— | —— | ||
| $2.67M+153% | $1.05M+108% | $506K-80.2% | $2.56M+181% | ||
| —— | $5.3M— | —— | $61.91M+17.3% | ||
| —— | —— | —— | —— | ||
| $80.06M+47.1% | $54.42M+11.5% | $48.81M+36.4% | $35.8M— | ||
| $60.93M+44.2% | $42.25M+6.7% | $39.59M+40.4% | $28.19M— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does National Health Investors's income statement data come from?
- Every line is extracted from National Health Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.